BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31500632)

  • 21. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
    Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
    Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.
    Hsu YL; Chen YJ; Chang WA; Jian SF; Fan HL; Wang JY; Kuo PL
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
    Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
    BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
    Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
    Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
    Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
    Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.
    Zhang T; Tseng C; Zhang Y; Sirin O; Corn PG; Li-Ning-Tapia EM; Troncoso P; Davis J; Pettaway C; Ward J; Frazier ML; Logothetis C; Kolonin MG
    Nat Commun; 2016 May; 7():11674. PubMed ID: 27241286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
    Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
    Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3.
    Schröder SK; Pinoé-Schmidt M; Weiskirchen R
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
    Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
    Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
    Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
    Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
    Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Zhu WB; Zhao ZF; Zhou X
    J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
    Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
    Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.
    Miyake M; Hori S; Morizawa Y; Tatsumi Y; Nakai Y; Anai S; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Toritsuka M; Kishimoto T; Rosser CJ; Fujimoto K
    Neoplasia; 2016 Oct; 18(10):636-646. PubMed ID: 27690238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.
    Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X
    Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
    He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
    Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.